Cognitive deficits in mood disorders are highly prevalent and impactful.
Few interventions have evidence of pro-cognitive effects in mood disorders.
In this pilot study we explored the cognitive effect of a GLP-1 R agonist.
4-week treatment with liraglutide was associated with cognitive improvements.
Liraglutide was also safe and well tolerated by individuals with mood disorders.